Skip to main content
. Author manuscript; available in PMC: 2011 Oct 12.
Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006690. doi: 10.1002/14651858.CD006690.pub2
Methods Parallel randomised controlled trial

Participants SETTING: Hospital outpatients and patients recruited from general company check-up,
Huabei Petroleum Two Hospital, Hebei, China
WHO PARTCIPATED: n=76 (40 in the intervention group M/F 31/19, mean age
44.2yrs; 36 in the control M/F 23/13, mean age 43.9yrs)
INCLUSION CRITERIA: IGT (ADA 1997): FBG <7.0 and 2hr-GTT (75g) ≥7.8 <11.1
EXCLUSION CRITERIA: <20yrs <65yrs; IGT induced by other disorders, drugs or
stress, pregnancy, serious liver, kidney or heart disorders.
CO-MORBIDITIES: none reported
CO-MEDICATIONS: none reported

Interventions INTERVENTION: Tang Kang Yin decoction (ren shen 6g, huang lian 10g, nu zhen zi
15g, xia ku cao 30g, fan shi liu ye 30g) oral, 200ml, 2x/day, plus lifestyle modification
(diet & exercise)
CONTROL: lifestyle modification (diet & lifestyle)

Outcomes Fasting blood glucose (mmol/L), 2hr-GTT (mmol/L), insulin (ng/ml), triglycerides
(mmol/L), total cholesterol (mmol/L), BMI, normalisation of fasting bloood glucose (n),
incidence of diabetes (n)
All outcomes were assessed at baseline and trial completion (30 days).
Study details DURATION OF INTERVENTION: 30 days
DURATION OF FOLLOW-UP: 30 days
RUN-IN PERIOD: none

Publication details LANGUAGE OF PUBLICATION: Chinese
COMMERCIAL FUNDING: no
NON-COMMERCIAL FUNDING: no
PUBLICATION STATUS (PEER REVIEW JOURNAL): no
PUBLICATION STATUS (JOURNAL SUPPLEMENT): no
PUBLICATION STATUS (ABSTRACT): yes

Stated aim of study Quote “To observe the clinical effect of intervention of Tangganyin decoction on
patients with Impaired glucose tolerance ( IGT) .”

Notes

Risk of bias table